Discouraging Non-ELISA antiphospholipid antibody assays in antiphospholipid syndrome classification may hinder clinical research
Immunol Res
.
2023 Dec 12.
doi: 10.1007/s12026-023-09443-8.
Online ahead of print.
Authors
Xiaochun Susan Zhang
1
2
,
Nicola Bizzaro
3
,
Anne E Tebo
4
,
Vijayalakshmi Nandakumar
5
,
Maria Infantino
6
,
Teresa Carbone
7
,
Xavier Bossuyt
8
,
Jan Damoiseaux
9
Affiliations
1
Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA. Susan.Zhang@uhhospitals.org.
2
Case Western Reserve University, School of Medicine, Cleveland, OH, USA. Susan.Zhang@uhhospitals.org.
3
Clinical Pathology, Azienda Sanitaria Universitaria Integrata, Udine, Italy.
4
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
5
University of Utah School of Medicine and ARUP Laboratories, Salt Lake City, UT, USA.
6
Laboratory of Immunology and Allergy, San Giovanni di Dio Hospital, Florence, Italy.
7
Immunopathology Laboratory, Regional San Carlo Hospital, Potenza, Italy.
8
Laboratory Medicine, UZ Leuven and Clinical and Diagnostic Immunology, KU Leuven, Louvain, Belgium.
9
Central Diagnostic Laboratory, University Medical Center, Maastricht, The Netherlands.
PMID:
38087183
DOI:
10.1007/s12026-023-09443-8
No abstract available
Publication types
Letter